Tempus AI, Inc. (TEM) EPS Diluted: -1.41
Is Tempus AI, Inc.’s EPS diluted high or low?
Tempus AI, Inc.'s EPS diluted of -1.41 is 35% above its 5-year average of -2.16, near the high end of its 5-year range (-4.60–-1.41).
53.08% above its 12-month average of -3.00.
TEM EPS Diluted Chart
TEM Average EPS Diluted Chart
TEM Current vs Average EPS Diluted Chart
TEM EPS Diluted Metrics
EPS DILUTED
-1.41
EPS DILUTED AVG TTM
-3.00
EPS DILUTED AVG 3Y
-2.43
EPS DILUTED AVG 5Y
-2.16
EPS DILUTED AVG 10Y
-1.98
EPS DILUTED AVG 15Y
-1.98
EPS DILUTED AVG 20Y
-1.98
CURRENT VS TTM AVG
+53.08%
CURRENT VS 3Y AVG
+41.92%
CURRENT VS 5Y AVG
+34.67%
CURRENT VS 10Y AVG
+28.84%
CURRENT VS 15Y AVG
+28.84%
CURRENT VS 20Y AVG
+28.84%
Tempus AI, Inc. EPS Diluted Formula & Definition
EPS Diluted includes the effect of convertible securities, options, and other potential shares. Compare it with basic EPS to see the impact of potential dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Tempus AI, Inc. EPS Diluted FAQ
- What is the EPS diluted for Tempus AI, Inc. (TEM)?
- The EPS diluted for TEM stock is -1.41.
- Is Tempus AI, Inc.'s EPS diluted high or low?
- Tempus AI, Inc.'s EPS diluted of -1.41 is 35% above its 5-year average of -2.16, near the high end of its 5-year range (-4.60–-1.41).
- What is the TTM average EPS diluted for Tempus AI, Inc. (TEM)?
- The TTM average EPS diluted for TEM stock is -3.00.
- What is the 3Y average EPS diluted for Tempus AI, Inc. (TEM)?
- The 3Y average EPS diluted for TEM stock is -2.43.
- What is the 5Y average EPS diluted for Tempus AI, Inc. (TEM)?
- The 5Y average EPS diluted for TEM stock is -2.16.
- What is the 10Y average EPS diluted for Tempus AI, Inc. (TEM)?
- The 10Y average EPS diluted for TEM stock is -1.98.
- What is the 15Y average EPS diluted for Tempus AI, Inc. (TEM)?
- The 15Y average EPS diluted for TEM stock is -1.98.
- What is the 20Y average EPS diluted for Tempus AI, Inc. (TEM)?
- The 20Y average EPS diluted for TEM stock is -1.98.
Tempus AI, Inc. EPS Diluted History
| DATE | EPS DILUTED |
|---|---|
| 2025-12-31 | -1.41 |
| 2024-12-31 | -4.60 |
| 2023-12-31 | -1.73 |
| 2022-12-31 | -1.97 |
| 2021-12-31 | -1.75 |
| 2020-12-31 | -1.49 |
| 2019-12-31 | -0.92 |
Related Metrics
About Tempus AI, Inc.
Tempus AI, Inc. functions as a pioneering health technology enterprise. It specializes in delivering advanced diagnostic services, including cutting-edge genomic sequencing, PCR analysis, molecular genotyping, and various other anatomical and molecular pathology assessments. These vital services are provided to a diverse clientele, including medical practitioners, pharmaceutical companies, biotechnology innovators, scientific researchers, and other collaborating entities. The company offers "Insights," a licensed repository of de-identified clinical, molecular, and imaging data, complemented by a comprehensive suite of analytical and cloud-based computing services, primarily aimed at pharmaceutical and biotechnology firms. Additionally, its "Trials" program facilitates clinical trial matching services specifically for pharmaceutical companies. Tempus AI also manages several other platforms: "Next"; "Algos," a collection of algorithm-driven tests focused on oncology; "Hub," a versatile desktop and mobile application for ordering, managing, and receiving test results for patients; and "Lens," a dedicated portal enabling researchers and scientists to discover, access, and analyze the extensive Tempus dataset. Further demonstrating its commitment to innovation, Tempus AI has formed strategic alliances with AstraZeneca and Pathos AI, Inc. for the co-development of oncological therapeutic initiatives. Established in 2015, the company was initially known as Tempus Labs, Inc. before officially rebranding to Tempus AI, Inc. in January 2023. Its operations are based out of Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Eric Lefkofsky